4//SEC Filing
DeLong Mark Jeffrey 4
Accession 0001127602-24-001931
CIK 0001492422other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 6:01 PM ET
Size
4.5 KB
Accession
0001127602-24-001931
Insider Transaction Report
Form 4
DeLong Mark Jeffrey
Chief Business & Strat Officer
Transactions
- Sale
Common Stock
2024-01-22$65.00/sh−1,384$89,954→ 65,570 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on 01/19/2024.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001856078
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 6:01 PM ET
- Size
- 4.5 KB